BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 35087403)

  • 1. Nanocarriers-Assisted Needle-Free Vaccine Delivery Through Oral and Intranasal Transmucosal Routes: A Novel Therapeutic Conduit.
    Mangla B; Javed S; Sultan MH; Ahsan W; Aggarwal G; Kohli K
    Front Pharmacol; 2021; 12():757761. PubMed ID: 35087403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications.
    Zhang H; Zhang J; Streisand JB
    Clin Pharmacokinet; 2002; 41(9):661-80. PubMed ID: 12126458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orotransmucosal drug delivery systems: a review.
    Madhav NV; Shakya AK; Shakya P; Singh K
    J Control Release; 2009 Nov; 140(1):2-11. PubMed ID: 19665039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Needle-free vaccine delivery.
    Giudice EL; Campbell JD
    Adv Drug Deliv Rev; 2006 Apr; 58(1):68-89. PubMed ID: 16564111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovalbumin and cholera toxin delivery to buccal mucus for immunization using microneedles and comparison of immunological response to transmucosal delivery.
    Oh YJ; Cha HR; Hwang SJ; Kim DS; Choi YJ; Kim YS; Shin YR; Nguyen TT; Choi SO; Lee JM; Park JH
    Drug Deliv Transl Res; 2021 Aug; 11(4):1390-1400. PubMed ID: 33759112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010720. PubMed ID: 30091147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in intranasal vaccine delivery: A promising non-invasive route of immunization.
    Kehagia E; Papakyriakopoulou P; Valsami G
    Vaccine; 2023 Jun; 41(24):3589-3603. PubMed ID: 37179163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palatal mucosa as a route for systemic drug delivery: A review.
    Shakya P; Madhav NV; Shakya AK; Singh K
    J Control Release; 2011 Apr; 151(1):2-9. PubMed ID: 21059376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances Towards Painless Vaccination and Newer Modes of Vaccine Delivery.
    Garg N; Aggarwal A
    Indian J Pediatr; 2018 Feb; 85(2):132-138. PubMed ID: 28620730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens.
    Amuguni H; Tzipori S
    Hum Vaccin Immunother; 2012 Jul; 8(7):979-86. PubMed ID: 22699442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanovaccines : nanocarriers for antigen delivery.
    Gonzalez-Aramundiz JV; Cordeiro AS; Csaba N; de la Fuente M; Alonso MJ
    Biol Aujourdhui; 2012; 206(4):249-61. PubMed ID: 23419252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal and sublingual delivery of inactivated polio vaccine.
    Kraan H; Soema P; Amorij JP; Kersten G
    Vaccine; 2017 May; 35(20):2647-2653. PubMed ID: 28400164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microneedle-Mediated Vaccine Delivery to the Oral Mucosa.
    Creighton RL; Woodrow KA
    Adv Healthc Mater; 2019 Feb; 8(4):e1801180. PubMed ID: 30537400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Double-Layer Dissolving Microneedles for Transmucosal Sequential Delivery of Multiple Drugs in the Treatment of Oral Mucosa Diseases.
    Meng Y; Li XJ; Li Y; Zhang TY; Liu D; Wu YQ; Hou FF; Ye L; Wu CJ; Feng XD; Ju XJ; Jiang L
    ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36892578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids.
    Grassin-Delyle S; Buenestado A; Naline E; Faisy C; Blouquit-Laye S; Couderc LJ; Le Guen M; Fischler M; Devillier P
    Pharmacol Ther; 2012 Jun; 134(3):366-79. PubMed ID: 22465159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids for the management of breakthrough pain in cancer patients.
    Zeppetella G; Davies AN
    Cochrane Database Syst Rev; 2013 Oct; (10):CD004311. PubMed ID: 24142465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Trends and Future Challenges of Nanovaccine Delivery
    Dewangan HK; Raghuvanshi A; Shah K
    Curr Drug Targets; 2023; 24(3):261-273. PubMed ID: 36475350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal route for vaccine and drug delivery: Features and current opportunities.
    Lobaina Mato Y
    Int J Pharm; 2019 Dec; 572():118813. PubMed ID: 31678521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging nanoplatform and vaccine delivery, a landscape of strategy to enhance nasal immunity.
    Teng Z; Meng LY; Yang JK; He Z; Chen XG; Liu Y
    J Control Release; 2022 Nov; 351():456-475. PubMed ID: 36174803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.